Physician profile
Evans S Smith
NPI 1871578989
$3,031.94
in general payments reported to CMS, 2019-2025
23 companies · $198 in 2025
The $198 reported for 2025 was more than what 82% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $465 · 2021: $282 · 2022: $447 · 2023: $901 · 2024: $155 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,253.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $900.94 | 2022-2025 | Xperience, Blastx, Surgx |
| Misonix INC | $677.78 | 2019-2021 | |
| Kci USA, INC. | $192.47 | 2019-2023 | Activ.A.C., 3m Cavilon, V.A.C. Dermatac |
| Smith+Nephew, INC. | $182.15 | 2019-2024 | Collagenase Santyl, Oasis, Grafix Pl |
| Organogenesis INC. | $153.07 | 2019-2020 | |
| Bsn Medical INC | $152.90 | 2023-2024 | |
| Acera Surgical, INC. | $134.14 | 2023 | Restrata Wound Matrix |
| E.R. Squibb & Sons, L.L.C. | $92.25 | 2019 | |
| Solventum Corporation | $87.41 | 2024-2025 | Activ.A.C., V.A.C. Dermatac, V.A.C. Veraflo |
| Paratek Pharmaceuticals, INC. | $75.04 | 2024-2025 | Nuzyra |
| Tei Medical INC. | $73.16 | 2019 | |
| Integra Lifesciences Corporation | $57.66 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $40.18 | 2022 | |
| Urgo Medical North America, LLC | $38.28 | 2025 | Urgoclean Ag |
| Vertex Pharmaceuticals Incorporated | $24.59 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $20.78 | 2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $20.69 | 2023 | Gattex |
| Ovik Health, LLC | $19.82 | 2025 | Assist Silver |
| Janssen Pharmaceuticals, INC | $19.18 | 2022 | |
| Kerecis Limited | $18.81 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Astrazeneca Pharmaceuticals Lp | $18.35 | 2021 | |
| Progenacare Global, LLC | $16.59 | 2023 | |
| Hydrofera LLC | $15.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evans Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.